- ≥99% by HPLC; lot-matched COA available
- Lot-matched certificate of analysis
- Ships next business day, tracked
Ovagen
Glu-Asp-Leu (EDL) tripeptide from the Khavinson short-peptide bioregulator series
- FormLyophilized powder in a sealed glass vial
- Mol. weight375.38 g/mol
- Research areasHepatic tissue models, protein synthesis markers, gene expression, comparative peptide studies
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
Ovagen is a synthetic tripeptide with the sequence L-glutamyl-L-aspartyl-L-leucine (Glu-Asp-Leu, or EDL). It comes from the Khavinson programme of short peptide bioregulators, in which tissue-derived peptide preparations were narrowed down to defined two-, three-, and four-residue sequences that could be synthesised reproducibly and characterised analytically.
Structurally, EDL pairs the acidic Glu-Asp motif that runs through much of the series with a hydrophobic C-terminal leucine, making it the tripeptide analogue of Bronchogen's tail chemistry. Our Ovagen is supplied as a 20 mg lyophilized vial, produced by solid-phase peptide synthesis and HPLC purified to a ≥99% specification, with a lot-matched certificate of analysis available. It is sold for laboratory research only.
Specifications
Identity
- Molecular formula
- C15H25N3O8
- Molecular weight
- 375.38 g/mol
- Amino acid sequence
- Glu-Asp-Leu (EDL), linear tripeptide
- Peptide class
- Khavinson short-peptide bioregulator (tripeptide)
Supply & purity
- Form
- Lyophilized powder in a sealed glass vial
- Purity
- ≥99% by HPLC; lot-matched COA available
- Available sizes
- 20 mg
- Solubility
- Bacteriostatic or sterile water; readily soluble in aqueous buffers
Handling & storage
- Storage (lyophilized)
- −20 °C, sealed and protected from light and moisture
- Storage (reconstituted)
- 2–8 °C, protected from light; use within the study window
Additional detail
- Tissue association
- Reported variously for hepatic and reproductive tissue preparations; verify against the cited study
- Research areas
- Hepatic tissue models, protein synthesis markers, gene expression, comparative peptide studies
- Sequence relationship
- Shares its C-terminal leucine with Bronchogen (AEDL)
Questions about Ovagen
What is Ovagen?
Ovagen is the synthetic tripeptide Glu-Asp-Leu (EDL) from the Khavinson short-peptide bioregulator series. It is supplied as a lyophilized research chemical for laboratory investigation and is not a medicine, supplement, or cosmetic ingredient.
Which tissue is it associated with?
Sources differ. Much of the Russian-language literature discusses EDL in hepatic and protein-synthesis contexts, while other summaries link the name to reproductive tissue. We list the ambiguity openly so researchers check the tissue actually studied in whichever paper they cite.
Is a certificate of analysis available?
Yes. Each lot is HPLC tested against a ≥99% purity specification and a lot-matched COA is available on request, recording the batch identifier, purity result, identity confirmation, and the physical description of the powder.
Why is no CAS number listed?
No widely accepted CAS registry entry is available for this sequence, so the field is left blank rather than populated with an unverified number. Identity rests on the amino acid sequence, molecular formula, and weight confirmed on the lot COA.
How should it be stored?
Store the unopened lyophilized vial at −20 °C, away from light and moisture. Once reconstituted, keep the solution at 2–8 °C for the planned study window, or freeze single-use aliquots to avoid repeated freeze-thaw cycles.
